Delivery Order SPE2DB20D2014-SPE2DB25FA88C
Award Date
1/27/25
Potential Completion Date
1/28/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,155.60 firm fixed-price delivery order is for the supply of 4,567,055,812 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp., a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $1,602.84 Firm Fixed Price Delivery Order (SPE2DB22D1106|SPE2DB25FDXB2) is for the supply of Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of February 3, 2025 and was awarded on February 1, 2025. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract (SPE2DB20D2002|SPE2DB25FL16L) was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,075,361 units of Oseltamivir Phosphate 75 mg capsules. The $3,240.77 firm fixed-price contract has a completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a leading pharmaceutical distributor, for the supply of Oseltamivir Phosphate 75 mg capsules. The contract, valued at $1,344.25, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of medical...
This federal contract award, valued at $2,124.60, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of Oseltamivir Phosphate 30 mg capsules. It is a Firm Fixed Price contract with an ultimate completion date of January 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,031.69 firm fixed-price delivery order is for the supply of 4567248922 units of the drug Oseltamivir Phosphate 75 mg capsules, and has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,328.80 Firm Fixed Price Delivery Order is for the supply of 4566728790 units of Oseltamivir Phosphate 75 mg capsules, a medication used to treat influenza. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,425.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of 4,564,007,468 units of Oseltamivir Phosphate 75mg capsules. The contract has an ultimate completion date of March 20, 2024 and is a Firm Fixed Price arrangement. AmerisourceBergen, a for-profit...
This federal contract award, SPE2DX15D1022|SPE2DX25FVCGJ, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, for the delivery of 4,567,255,133 units of Oseltamivir Phosphate 75 mg capsules. The contract has a ceiling value of $1,993.20 and is a Firm Fixed Price Delivery Order with a period of performance through February 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, with the ID SPE2DB20D2002|SPE2DB24FL17J, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,140.40, is for the delivery of 4,563,352,666 units of Oseltamivir Phosphate 75mg Capsules. This is a Firm Fixed Price Delivery Order contract with a period of performance through January 19, 2024. The contract does not have a set-aside designation, indicating it was...